Browse All
Displaying 1 - 1 of 1
Author:Fox, Robert J. Bar-Or, Amit Traboulsee, Anthony Oreja-Guevara, Celia Giovannoni, Gavin Vermersch, Patrick Syed, Sana Li, Ye Vargas, Wendy S. Turner, Timothy J. Wallstroem, Erik Reich, Daniel S.
Session Name:PL5: Clinical Trials Plenary Session
Topic:Multiple Sclerosis
Program Number:PL5.003
Author Institution:Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, United States, Cleveland, OH Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology, University of Pennsylvania, Philadelphia, United States, Philadelphia, PA The University of British Columbia, Division of Neurology, Vancouver, Canada, Vancouver, BC, Canada Multiple Sclerosis Center, University Hospital San Carlos, Madrid, Spain, Madrid, Spain Queen Mary University London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom, London, United Kingdom University of Lille, Inserm U1172, CHU Lille, FHU Precise, Lille, France, Lille, France Sanofi, Cambridge, United States, Cambridge, MA Sanofi, Bridgewater, United States, Bridgewater, NJ Translational Neuroradiology Section, National Institutes of Health, Bethesda, United States, Bethesda, MD
